George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpire Healthcare Regulatory News (SPI)

Share Price Information for Spire Healthcare (SPI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 246.50
Bid: 247.00
Ask: 248.00
Change: -0.50 (-0.20%)
Spread: 1.00 (0.405%)
Open: 245.50
High: 248.50
Low: 245.50
Prev. Close: 247.00
SPI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Spire Healthcare group plc

3 Nov 2017 15:20

RNS Number : 5538V
BlackRock Group
03 November 2017
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

(a) Full name of discloser:

BlackRock, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Spire Healthcare Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

02 November 2017

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes, Mediclinic International plc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

1p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

19,284,609

4.80%

0

0.00%

(2) Cash-settled derivatives:

 

0

0.00%

76,962

0.01%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00%

0

0.00%

 

TOTAL:

19,284,609

4.80%

76,962

0.01%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

1p ordinary

Purchase

2,707

GBP 3.0040

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

1p ordinary

CFD

Reducing short

28,207

GBP 2.9909

1p ordinary

CFD

Increasing short

561

GBP 2.9577

1p ordinary

CFD

Increasing short

603

GBP 2.9677

1p ordinary

CFD

Increasing short

519

GBP 2.9747

1p ordinary

CFD

Increasing short

717

GBP 2.9777

1p ordinary

CFD

Increasing short

813

GBP 2.9817

1p ordinary

CFD

Increasing short

61

GBP 2.9837

1p ordinary

CFD

Increasing short

985

GBP 2.9847

1p ordinary

CFD

Increasing short

1,812

GBP 2.9867

1p ordinary

CFD

Increasing short

727

GBP 2.9877

1p ordinary

CFD

Increasing short

26

GBP 2.9897

1p ordinary

CFD

Increasing short

1,393

GBP 2.9997

1p ordinary

CFD

Increasing short

212

GBP 3.0017

1p ordinary

CFD

Increasing short

784

GBP 3.0037

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

1p ordinary

Transfer In of Shares

13,384

1p ordinary

Transfer In of Shares

494

1p ordinary

Transfer Out of Shares

13,384

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

Date of disclosure:

03 November 2017

Contact name:

Andrew Manchester

Telephone number:

+44 20 7743 3650

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETOKNDBNBDDDDK
Date   Source Headline
14th Oct 202210:00 amRNSChanges to Board of Directors and committees
3rd Oct 20224:04 pmRNSTotal Voting Rights
30th Sep 20227:00 amRNSBlock Listing Six Monthly Return
8th Sep 20227:00 amRNSInterim Results
1st Sep 20229:51 amRNSTotal Voting Rights
23rd Aug 20222:55 pmRNSHolding(s) in Company
15th Aug 20227:00 amRNSNotice of Interim Results
4th Aug 20222:11 pmRNSHolding(s) in Company
1st Aug 20222:43 pmRNSTotal Voting Rights
19th Jul 20229:07 amRNSBlock listing Interim Review
14th Jul 20223:48 pmRNSHolding(s) in Company
13th Jul 20224:43 pmRNSHolding(s) in Company
6th Jul 20224:00 pmRNSDirector/PDMR Shareholding
1st Jul 202210:28 amRNSTotal Voting Rights
29th Jun 20223:56 pmRNSHolding(s) in Company
29th Jun 20227:00 amRNSCapital Markets Event and new agreement with BUPA
1st Jun 20227:54 amRNSTotal Voting Rights
19th May 20227:44 amRNSHolding(s) in Company
18th May 20223:15 pmRNSHolding(s) in Company
13th May 202210:43 amRNSDirector/PDMR Shareholding
11th May 20224:25 pmRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
6th May 20227:00 amRNSNotice of Capital Markets Day
3rd May 20228:46 amRNSTotal Voting Rights
27th Apr 20223:49 pmRNSDirector/PDMR Shareholding
6th Apr 20229:55 amRNSDirector/PDMR Shareholding
1st Apr 20224:40 pmRNS2021 Annual Report and 2022 Notice of AGM
1st Apr 202212:32 pmRNSHolding(s) in Company
1st Apr 202211:10 amRNSTotal Voting Rights
25th Mar 20222:51 pmRNSBlock listing application
24th Mar 20225:16 pmRNSHolding(s) in Company
16th Mar 20228:07 amRNSDirector/PDMR Shareholding
9th Mar 20227:43 amRNSHolding(s) in Company
4th Mar 20226:12 pmRNSHolding(s) in Company
4th Mar 20223:14 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSFinal Results
1st Mar 20227:23 amRNSTotal Voting Rights
25th Feb 202212:21 pmRNSHolding(s) in Company
25th Feb 20227:00 amRNSRe-financing of funding facilities
22nd Feb 20223:26 pmRNSHolding(s) in Company
22nd Feb 20221:38 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSManagement update
8th Feb 20227:00 amRNSNotice of Preliminary Results
1st Feb 20229:29 amRNSTotal Voting Rights
27th Jan 20222:57 pmRNSTotal Voting Rights
18th Jan 20227:00 amRNSUpdate on shareholder views
13th Jan 20224:52 pmRNSHolding(s) in Company
12th Jan 20222:40 pmRNSHolding(s) in Company
12th Jan 20222:38 pmRNSHolding(s) in Company
11th Jan 202210:14 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.